Home/Filings/4/0001209191-21-039933
4//SEC Filing

Griggs Jonathan 4

Accession 0001209191-21-039933

CIK 0001087294other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:19 PM ET

Size

6.4 KB

Accession

0001209191-21-039933

Insider Transaction Report

Form 4
Period: 2021-03-17
Transactions
  • Award

    Common Stock

    2021-03-17$3.22/sh+1,000$3,22014,803 total
Footnotes (1)
  • [F1]Restricted stock award will vest 100% on March 17, 2022.

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1
  • filerCIK 0001490828

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:19 PM ET
Size
6.4 KB